Evidence map›Paper›PMID 42595485›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2026

Clinical Trial Protocol for LPS-Boost: Intensified [

Amir Iravani, Roman Gulati, Robert Miyaoka, Angela Castellanos Reiger, Delphine L Chen, Meena Kumar, Mark Erickson, Katie Nega, Catherine Meyer, Stephanie Lira and 18 more

Abstract readClinical Trial Protocol
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Amir IravaniDepartment of Radiology, University of Washington, Seattle, Washington; airavani@uw.edu.
Roman GulatiPublic Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington.
Robert MiyaokaDepartment of Radiology, University of Washington, Seattle, Washington.
Angela Castellanos ReigerDepartment of Radiology, University of Washington, Seattle, Washington.
Delphine L ChenDepartment of Radiology, University of Washington, Seattle, Washington.
Meena KumarDepartment of Radiology, University of Washington, Seattle, Washington.
Mark EricksonDepartment of Radiology, University of Washington, Seattle, Washington.
Katie NegaDepartment of Radiology, University of Washington, Seattle, Washington.
Catherine MeyerDepartment of Nuclear Medicine and Theranostics, University of California Los Angeles, Los Angeles, California.
Stephanie LiraDepartment of Nuclear Medicine and Theranostics, University of California Los Angeles, Los Angeles, California.
Youngho SeoDepartment of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California.
Robert R FlavellDepartment of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California.
Collin C PritchardDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington.
Michael C HaffnerDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington.
Rosa Nadal RiosClinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.
Rajitha SunkaraClinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.
Hiba M KhanClinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.
Todd YezefskiClinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.
Ruben RaychaudhuriClinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.
Andrew C HsiehClinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.
Petros GrivasClinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.
Heather H ChengClinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.
Evan Y YuClinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.
Michael T SchweizerClinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.
Peter S NelsonClinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.
Johannes CzerninDepartment of Nuclear Medicine and Theranostics, University of California Los Angeles, Los Angeles, California.
Thomas A HopeDepartment of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California.
Jeremie CalaisDepartment of Nuclear Medicine and Theranostics, University of California Los Angeles, Los Angeles, California.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[

Indexed as

Antigens, SurfaceDipeptidesGene Expression Regulation, NeoplasticGlutamate Carboxypeptidase IIHeterocyclic Compounds, 1-RingLutetiumProstatic Neoplasms, Castration-ResistantAgedClinical Trials, Phase II as TopicHumansMaleMiddle AgedMulticenter Studies as TopicNeoplasm MetastasisProstate-Specific AntigenRadioisotopesAntigens, SurfaceDipeptidesFOLH1 protein, humanGlutamate Carboxypeptidase IIHeterocyclic Compounds, 1-RingLutetiumLutetium-177lutetium (177Lu) vipivotide tetraxetanProstate-Specific AntigenPSMA-617Radioisotopes177Lu-PSMA-617metastatic castration-resistant prostate cancerPSMA expressionPSMA PETradiopharmaceutical therapy

Identifiers

PMID42595485
PMCPMC13635057

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.